<p>† Recommendation that has changed since 2017.</p>

<p>‡ Severe SLE indicates organ-threatening disease.</p>

<p>§ Drug added for 2022 update.</p>

<p>¶ For patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or all SLE for whom antirheumatic therapy was withheld prior to undergoing total joint arthroplasty, antirheumatic therapy should be restarted once the wound shows evidence of healing, any sutures/staples are out, there is no signiﬁcant swelling, erythema, or drainage, and there is no ongoing nonsurgical site infection, which is typically ~14 days.</p>

<h1>Recommendation pertains to infection risk and does not account for risk of cardiac events or venous thromboembolism.</h1>

<h1>RESULTS/RECOMMENDATIONS</h1>